Two children with Guillain-Barrè syndrome were successfully treated with high-dose intravenous immunoglobulin (IVIG) and no relapses occurred over a 1 year follow up. No side-effects were observed. These data provide further evidence that IVIG may be safely and effectively employed in children with Guillain-Barrè syndrome.
Intravenous immunoglobulin in two children with Guillain-Barré syndrome / L. D., Notarangelo; Duse, Marzia; S., Tiberti; B., Guarneri; A., Brunori; A., Negrini; A. G., Ugazio. - In: EUROPEAN JOURNAL OF PEDIATRICS. - ISSN 0340-6199. - STAMPA. - 152:(1993), pp. 372-374. [10.1007/BF01956757]
Intravenous immunoglobulin in two children with Guillain-Barré syndrome.
DUSE, MARZIA;
1993
Abstract
Two children with Guillain-Barrè syndrome were successfully treated with high-dose intravenous immunoglobulin (IVIG) and no relapses occurred over a 1 year follow up. No side-effects were observed. These data provide further evidence that IVIG may be safely and effectively employed in children with Guillain-Barrè syndrome.File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
